课题基金 / 基金详情

TRTech-PGR: Ensifer-mediated Transformation as an Alternative to Agrobacterium-mediated Plant Transformation of Model Plants and Crops

TRTech-PGR: Ensifer-mediated Transformation as an Alternative to Agrobacterium-mediated Plant Transformation of Model Plants and Crops
TRTech-PGR:Ensifer 介导的转化作为模型植物和作物农杆菌介导的植物转化的替代方案
批准号:
2006668
负责人:
Stanton Gelvin
金额:
$119.62万
依托单位:
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-01 至 2025-06-30

项目摘要

项目成果

Stanton Gelvin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Agrobacterium-mediated plant genetic transformation (AMT) is the most commonly used technology for generating transgenic plants and introducing genome engineering reagents in plant basic research and in agricultural biotechnology. Although this technology was developed and used for plant improvement since the 1980s, Agrobacterium-mediated transformation has numerous limitations. Key among these is that Agrobacterium-mediated transformation is limited to specific plant species and/or varieties of particular plant species. Agrobacterium is a natural plant pathogen, and it therefore frequently elicits defense reactions from infected plants, causing tissue necrosis. Such necrotic tissue cannot be genetically transformed. Ensifer adhaerens is a bacterium related to Agrobacterium. When supplied with the relevant genetic elements it can, like Agrobacterium, genetically transform plants. Ensifer is not a pathogen and therefore fails to elicit necrotic plant defense responses. However, Ensifer-mediated plant genetic transformation remains inefficient and cumbersome to perform in the average plant biology laboratory. The work described in this project will develop an Ensifer-mediated plant genetic transformation system, greatly simplifying the use of Ensifer in the laboratory and improving the efficiency of Ensifer-mediated transformation. The resulting system will greatly extend the host range for plant transformation, allowing for the genetic improvement of a wider range of crop species than that now permitted by Agrobacterium-mediated transformation. Agrobacterium-mediated plant genetic transformation has been used for transformation of many plant species. However, numerous plant species and cultivars/varieties remain highly recalcitrant to Agrobacterium-mediated transformation, in part because they react with a necrotic defense response to Agrobacterium infection. As a non-pathogen, the related bacterium Ensifer adhaerens does not elicit a strong plant defense response. Ensifer can, with the appropriate genetic alterations, transform a wide spectrum of plant species. A limitation to using Ensifer as an alternative to Agrobacterium is that the best Ensifer strain currently used for plant transformation, E. adhaerens OV14, is naturally resistant to many antibiotics commonly used to manipulate Agrobacterium. To develop Ensifer-mediated transformation, this project will first delete Ensifer genes responsible for kanamycin resistance. Once a kanamycin-sensitive strain is created, various virulence (vir) gene complements from different Agrobacterium strains will be introduced into it, including the trans-zeatin synthase (tzs) gene that directs synthesis of cytokinins, that potentiates plant transformation susceptibility, and a virG mutant (N54D) allele that permits vir gene induction in the absence of phenolic compounds such as acetosyringone. These novel Ensifer strains harboring various vir gene complements will initially be compared to equivalent Agrobacterium strains for virulence on several model plant species, including Arabidopsis and tobacco. Finally, the transformation efficiency of the best Ensifer strains will be compared with equivalent Agrobacterium strains on various cultivars of two crop species: soybean (which is highly recalcitrant to AMT) and potato (many cultivars of which react to AMT with a necrotic response).This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BTT EAGER: Clean genome editing through the use of nonintegrating T-DNA technology
  • 批准号:
    1848434
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $30.0万
  • 财政年份:
    2019
  • 负责人:
    Stanton Gelvin
  • 依托单位:
TRANSFORM-PGR: Manipulating Agrobacterium-mediated transformation and T-DNA integration for plant synthetic biology and genome engineering
  • 批准号:
    1725122
  • 项目类别:
    Standard Grant
  • 资助金额:
    $146.71万
  • 财政年份:
    2017
  • 负责人:
    Stanton Gelvin
  • 依托单位:
Collaborative Research: Novel Proteins Required for Gene Transfer to Plants
  • 批准号:
    1049836
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $30.0万
  • 财政年份:
    2011
  • 负责人:
    Stanton Gelvin
  • 依托单位:
Formation and characterization of the Agrobacterium T-complex in plant cells
  • 批准号:
    0919931
  • 项目类别:
    Standard Grant
  • 资助金额:
    $40.0万
  • 财政年份:
    2009
  • 负责人:
    Stanton Gelvin
  • 依托单位:
国内基金
海外基金
TET2去甲基化上调CAV1表达介导PGR泛素化降解在妊娠期显性糖尿病并发子痫前期蜕膜化障碍中的作用及干预研究
  • 批准号:
    JCZRLH202600862
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
E3连接酶RNF213导致PGR缺陷在子宫内膜蜕膜化中的作用机制研究
  • 批准号:
    --
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    林忠
  • 依托单位:
孕激素通过 PGR/RUNX 调控胎盘 ASPROSIN 转录介 导妊娠期糖尿病
  • 批准号:
    2024JJ5350
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    洪涛
  • 依托单位:
通过构建Pgr-Cas9工具小鼠研究Hippo通路效应因子Yap1/Wwtr1在蜕膜化过程中的作用
  • 批准号:
    32370913
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    刘极龙
  • 依托单位: